US Stock MarketDetailed Quotes
LXRX Lexicon Pharmaceuticals
- 0.801
- -0.006-0.79%
Trading Nov 21 13:47 ET
289.56MMarket Cap-1082P/E (TTM)
0.835High0.763Low2.67MVolume0.801Open0.807Pre Close2.12MTurnover1.47%Turnover RatioLossP/E (Static)361.49MShares3.73052wk High1.62P/B145.90MFloat Cap0.76352wk Low--Dividend TTM182.14MShs Float344.750Historical High--Div YieldTTM8.83%Amplitude0.763Historical Low0.791Avg Price1Lot Size
Lexicon Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -28.83%-53.62M | -27.34%-48.54M | -74.39%-55.13M | -82.21%-161.9M | -134.35%-50.55M | -114.10%-41.62M | -56.08%-38.12M | -34.98%-31.61M | -2.11%-88.85M | 5.52%-21.57M |
| Net income from continuing operations | -28.28%-64.81M | -18.98%-53.43M | -51.55%-48.4M | -73.74%-177.12M | -63.17%-49.76M | -116.04%-50.53M | -82.63%-44.9M | -36.03%-31.93M | -16.16%-101.94M | -19.07%-30.49M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -93.88%3K | ---- |
| Depreciation and amortization | -16.56%126K | -3.47%139K | 28.57%144K | 29.74%554K | 42.72%147K | 39.81%151K | 34.58%144K | 2.75%112K | 46.23%427K | -8.04%103K |
| Other non cash items | 869.74%5.99M | -1,696.70%-4.36M | 9.81%291K | -414.57%-2.33M | -1,110.72%-3.49M | 184.79%618K | 77.27%273K | 960.00%265K | 1,272.22%741K | 4,212.50%345K |
| Change In working capital | 23.41%9.69M | 66.34%4.25M | -230.45%-11.47M | 561.44%2.66M | -182.16%-4.28M | 705.33%7.85M | 187.26%2.56M | -21.75%-3.47M | 103.93%402K | 1,248.70%5.21M |
| -Change in receivables | -174.93%-275K | -158.63%-1.09M | -120.51%-516K | -6,914.29%-982K | -5,866.67%-692K | 6,216.67%367K | -14,200.00%-423K | -917.39%-234K | -103.67%-14K | 33.33%12K |
| -Change in inventory | 68.90%-51K | 58.72%-71K | ---133K | ---381K | ---45K | ---164K | ---172K | --0 | --0 | --0 |
| -Change in prepaid assets | -43.27%969K | 76.01%-666K | -116.72%-1.88M | -817.41%-2.9M | -725.97%-964K | 551.91%1.71M | -176.22%-2.78M | -417.58%-867K | -110.95%-316K | -82.89%154K |
| -Change in payables and accrued expense | 45.12%8.87M | 2.52%5.91M | -228.81%-9.11M | 8,392.11%6.45M | -156.31%-2.65M | 654.69%6.11M | 369.52%5.77M | 16.26%-2.77M | 100.54%76K | 750.07%4.71M |
| -Change in other current assets | 202.33%176K | 6.21%171K | -58.50%166K | -28.81%467K | -76.15%78K | -89.01%-172K | -24.41%161K | 93.24%400K | -0.76%656K | 61.88%327K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -28.83%-53.62M | -27.34%-48.54M | -74.39%-55.13M | -82.21%-161.9M | -134.35%-50.55M | -114.10%-41.62M | -56.08%-38.12M | -34.98%-31.61M | -2.11%-88.85M | 5.52%-21.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 235.96%53.47M | 83.48%-12.32M | -1,011.47%-110.22M | 29.73%-49.94M | 114.69%51.9M | 49.06%-39.33M | -446.66%-74.61M | 374.34%12.09M | -3,468.63%-71.08M | 296.56%24.17M |
| Net PPE purchase and sale | -269.88%-307K | -79.86%-250K | --0 | 64.56%-470K | --0 | -1,975.00%-83K | ---139K | -226.32%-248K | -8.60%-1.33M | -5,317.39%-1.25M |
| Net investment purchase and sale | 237.03%53.78M | 83.79%-12.07M | -993.15%-110.22M | 29.07%-49.47M | 104.16%51.9M | 49.16%-39.24M | -445.64%-74.47M | 384.88%12.34M | -2,194.03%-69.75M | 315.43%25.42M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 235.96%53.47M | 83.48%-12.32M | -1,011.47%-110.22M | 29.73%-49.94M | 114.69%51.9M | 49.06%-39.33M | -446.66%-74.61M | 374.34%12.09M | -3,468.63%-71.08M | 296.56%24.17M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -336.19%-916K | -100.01%-14K | 29,151.33%239.38M | 32.17%187.96M | -100.00%-1K | -100.22%-210K | 189M | -103.54%-824K | 526.22%142.21M | 320.00%24.91M |
| Net issuance payments of debt | --0 | ---- | ---- | 2.24%49.96M | -100.00%-1K | 100.40%1K | ---- | ---- | 517.68%48.87M | 313.41%24.97M |
| Net common stock issuance | --0 | -100.00%1K | -99.27%-1.64M | 47.84%138M | --0 | -100.22%-211K | --139.03M | 4.63%-824K | 171.27%93.34M | -116.62%-63K |
| Net preferred stock issuance | ---10K | ---15K | --241.43M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | ---906K | --0 | ---400K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -336.19%-916K | -100.01%-14K | 29,151.33%239.38M | 32.17%187.96M | -100.00%-1K | -100.22%-210K | --189M | -103.54%-824K | 526.22%142.21M | 320.00%24.91M |
| Net cash flow | ||||||||||
| Beginning cash position | -65.17%35.62M | 271.12%96.49M | -51.53%22.47M | -27.66%46.35M | 12.12%21.12M | 376.79%102.27M | -56.32%26M | -27.66%46.35M | -49.26%64.07M | -79.55%18.83M |
| Current changes in cash | 98.69%-1.07M | -179.82%-60.88M | 463.89%74.03M | -34.76%-23.88M | -95.10%1.35M | -3,002.26%-81.16M | 300.34%76.27M | -347.61%-20.34M | 71.51%-17.72M | 198.07%27.51M |
| End cash Position | 63.62%34.55M | -65.17%35.62M | 271.12%96.49M | -51.53%22.47M | -51.53%22.47M | 12.12%21.12M | 376.79%102.27M | -56.32%26M | -27.66%46.35M | -27.66%46.35M |
| Free cash flow | -29.31%-53.93M | -27.54%-48.79M | -73.03%-55.13M | -80.05%-162.37M | -121.56%-50.55M | -114.48%-41.7M | -56.65%-38.26M | -35.60%-31.86M | -2.20%-90.18M | 0.16%-22.82M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data